NEW YORK, September 12, 2013 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new open access research publication - Journal of Clinical and Translational Endocrinology (JCTE).

The scope of this new journal is patient-oriented research in a variety of disciplines in endocrinology, including diabetes, metabolic bone disease and osteoporosis, thyroid disease, pituitary and lipid disorders. Areas of high priority include novel pilot/proof-of-concept clinical trials in humans and basic science research involving human specimens.

Dr. Vin Tangpricha from Emory University, Atlanta, Editor-in-Chief of the journal, said, "Journal of Clinical and Translational Endocrinology will provide authors a unique home for manuscripts focused on patient-oriented endocrinology research that translates basic science research to clinical applications for patients with endocrine diseases. As a practicing clinician and a researcher in endocrinology, I understand the importance of strengthening the relationship between the clinical and basic sciences. We look forward to providing the scientific community with high-yield content that addresses the needs of readers and investigators interested in translational research of endocrine diseases."

Andrew Miller, Executive Publisher at Elsevier, added, "Journal of Clinical and Translational Endocrinology will offer the research community a unique and dynamic blend of tradition and innovation: editorial review from an expert team of researchers together with our publishing and dissemination systems, involving innovative, digital approaches. Elsevier is very pleased to launch JCTE and work with Dr. Tangpricha and the journal editors to serve the needs of endocrinologists internationally."

For more information or to submit an article, go to: www.JCTEjournal.com. The journal is ready to accept submissions.

About the Editor-in-Chief: Dr. Vin Tangpricha, MD, PhD

Dr. Vin Tangpricha is an Associate Professor of Medicine at Emory University School of Medicine in the Division of Endocrinology, Metabolism and Lipids. He received his M.D. at Tufts University and completed his internal medicine residency and endocrinology fellowship at Boston University Medical Center. He completed a PhD in Molecular Medicine on the topic of colon cancer and vitamin D. Dr. Tangpricha has published a number of manuscripts investigating the role of vitamin D in patients with chronic kidney disease, cystic fibrosis, and infections including HIV and TB. He is currently conducting a number of clinical trials to translate findings from the bench that suggest that vitamin D may play an important role in improving outcomes in patients with infections.

About Open Access Publishing at Elsevier

Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as 52 full open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit www.elsevier.com/openaccess

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV.

Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.

Media contactBrant EmeryElsevier+31(0)20-485-3310b.emery@elsevier.com

SOURCE Elsevier